Cytokinetics
Kimberly Erby currently serves as the Director of Clinical Operations at Cytokinetics, where responsibilities include co-leading the Clinical Operations Department and overseeing the Cardiovascular portfolio across all clinical phases, along with establishing quality standards for the organization. Previously, Kimberly held the position of Associate Director of Medical Affairs at Dynavax Technologies, contributing significantly to the management team and ensuring quality standards while overseeing clinical operations and medical affairs. Additional experience includes roles as Director of Clinical Operations at Nuon Therapeutics, Clinical Program Manager at CoMentis, Inc., and Clinical Operations Consultant at Fibrogen, Inc., as well as a Clinical Development Consultant at Genentech. Kimberly earned a B.S. in Biology from Stanford University.
Cytokinetics
15 followers
Cytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators as potential treatments for people with diseases characterized by impaired or declining muscle function.